*
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read ProMIS Neurosciences’s 8K filing here.
ProMIS Neurosciences Company Profile
ProMIS Neurosciences, Inc discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company’s proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins.
Further Reading
- Five stocks we like better than ProMIS Neurosciences
- What is a Death Cross in Stocks?
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- What is the S&P/TSX Index?
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Pros And Cons Of Monthly Dividend Stocks
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
